Gefitinib and liver function test abnormal 
Gefitinib and liver function test abnormal Patient Reports February 12, 2012
Gefitinib Side Effects Report #4920025-7
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, disease progression, intestinal obstruction, liver function test abnormal, oral intake reduced, pain , renal failure, somnolence. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4928992-2
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, intestinal obstruction, liver function test abnormal, malignant neoplasm progression, non-small cell lung cancer, overgrowth bacterial, pain , pancreatic insufficiency. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4941031-2
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, intestinal obstruction, liver function test abnormal, malignant neoplasm progression, non-small cell lung cancer, oral intake reduced, overgrowth bacterial, pain . Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4951438-5
Gefitinib side effect was reported by a Physician from UNITED KINGDOM on July 20, 2005. Male patient, weighting 133.2 lb, was diagnosed with non-small cell lung cancer, analgesic effect, depression
, insomnia, pain , muscle spasms and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, disease progression, intestinal obstruction, liver function test abnormal, overgrowth bacterial, pancreatic insufficiency, renal failure, somnolence. Gefitinib dosage: unknown. During the same period patient was treated with GABAPENTIN, ACETAMINOPHEN, CARBAMAZEPINE, VENLAFAXINE, CLONAZEPAM, HALOPERIDOL, BUSCOPAN. Patient was hospitalized. Patient recovered.Gefitinib Side Effects Report #4664840-6
Gefitinib side effect was reported by a Pharmacist from on May 17, 2005. Male patient, 67 years of age, weighting 161.0 lb, was diagnosed with lung neoplasm malignant, dyslipidaemia and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, chromaturia, hepatotoxicity, liver function test abnormal, lung neoplasm malignant, myalgia. Gefitinib dosage: 250MG PO DAILY. During the same period patient was treated with SIMVASTATIN, GEMFIBROZIL. Patient was hospitalized. Patient recovered.